On August 30, PVH Corp. released Q2 2022 financials and surprised the market by cutting full-year projections. At the same time, the Com...

On March 8, 2022, Stitch Fix provided a weak outlook for its Q3 2022 and cut its revenue guidance for the full year. Also, Stitch Fix ann...

On July 13, 2022, The Korea Times published an article reporting that Coupang was under investigation for falsely advertising the members...

There are grounds to suspect that the Company disclosed information in bad faith as part of the initial offering in March 2021, including...

On August 29, 2022, the Company disclosed among other things that " it received a whistleblower complaint in May 2022 alleging potential ...

On July 28, 2022, Consumer Financial Protection Bureau (CFPB) Fines U.S. Bank $37.5 Million for Illegally Exploiting Personal Data to Ope...

On August 29, 2022, Reuters reported that "Elon Musk has sent an additional letter of deal termination to Twitter Inc to include a recent...

On June 15, 2022, CNBC published an article “Sen. Warren asks bank regulator to reject TD’s $13.4 billion acquisition after customer-abu...

On November 16, 2021, the company disclosed that "a planned futility analysis of ensovibep in [an] ongoing [Phase 3] clinical study . . ....

On July 25, 2022, WWE filed the SEC report which announced that “the Company has made a preliminary determination that certain payments t...

On July 25, 2022, WWE filed the SEC report which announced that “the Company has made a preliminary determination that certain payments t...

On March 17, 2022, a Beijing News reported that Chinese regulators launched a probe into Dingdong for food safety violations uncovered by...

On March 17, 2022, a Beijing News reported that Chinese regulators launched a probe into Dingdong for food safety violations uncovered by...

On July 11, 2022, NIO announced that in response to the allegations made in a report issued by the short-seller firm Grizzly Research LLC...

On July 13, 2022, Humanigen disclosed that lenzilumab had failed to show statistical significance on the primary endpoint of the ACTIV-5/...

On September 9, 2021, Humanigen issued a press release announcing that the FDA had rejected the lenzilumab EUA, advising investors that, ...

On July 12, 2022, market analyst Muddy Waters Research published a report summarising: "We are short Hannon Armstrong Sustainable Infrast...

Seeking Alpha published an article reporting on analyst speculation that CEO Hochschild’s resignation was directly tied to DFS’s recently...